Intended Use

The Dreem 3S is intended for prescription use to measure, record, display, transmit and analyze the electrical activity of the brain to assess sleep in the home or healthcare environment. It can output a hypnogram of sleep scoring by 30-second epoch and summary of sleep metrics derived from this hypnogram. Used for assessment of sleep on adults 22 to 65 years old.

Technology

The Dreem 3S is a flexible headband device containing 6 EEG electrodes and a 3D accelerometer for head movement. It includes a bone conduction speaker and an LED power indicator. Raw EEG and accelerometer data are sent to servers for analysis. The sleep staging algorithm is an artificial neural network that processes EEG and accelerometer data, including recurrent and attention layers, providing automatic 30-second epoch staging. The device generates reports in PDF and raw data files in EDF format.

Performance

No new clinical, bench, or animal testing performed. Performance characteristics rely on previous version (predicate K223539). The device includes a Predetermined Change Control Plan (PCCP) allowing planned updates to signal preprocessing, machine learning model, and probability post-processing algorithms to improve sleep staging, with validation and verification conducted on each modification to ensure clinical performance is non-inferior.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    7/17/2024

    4 months
  • 2

    FDA Approval

    11/22/2024

Other devices from Beacon Biosignals, Inc.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.